Satoshi Egawa

Satoshi Egawa

Auto-generated profile, based on publicly available information

Satoshi Egawa

Department of Gastroenterology and Hepatology, Kinki Central Hospital , Itami

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ATAyaka Tajiri
Ayaka Tajiri
RIRyu Ishihara
Ryu Ishihara
YKYusuke Kato
Yusuke Kato
TITakahiro Inoue
Takahiro Inoue
KMKatsunori Matsueda
Katsunori Matsueda
TTTomohiro Tada
Tomohiro Tada
Previous reports have shown favorable performance of artificial intelligence (AI) systems for diagnosing esophageal squamous cell carcinoma (ESCC) compared with endoscopists. However, these findings don’t reflect performance in clinical situations, as endoscopists classify lesions based on both magnified and non-magnified videos, while AI systems often use only a few magnified narrow band imaging (NBI) still images. We evaluated the performance of the AI system in simulated clinical situations. We used 25,048 images from 1433 superficial ESCC and 4746 images from 410 noncancerous esophagi to construct our AI system. For the validation dataset, we took NBI videos of suspected superficial ESCCs. The AI system diagnosis used one magnified still image taken from each video, while 19 endoscopists used whole videos. We used 147 videos and still images including 83 superficial ESCC and 64 non-ESCC lesions. The accuracy, sensitivity and specificity for the classification of ESCC were, respectively, 80.9% [95% CI 73.6–87.0], 85.5% [76.1–92.3], and 75.0% [62.6–85.0] for the AI system and 69.2% [66.4–72.1], 67.5% [61.4–73.6], and 71.5% [61.9–81.0] for the endoscopists. The AI system correctly classified all ESCCs invading the muscularis mucosa or submucosa and 96.8% of lesions ≥ 20 mm, whereas even the experts diagnosed some of them as non-ESCCs. Our AI system showed higher accuracy for classifying ESCC and non-ESCC than endoscopists. It may provide valuable diagnostic support to endoscopists.

1 January 2017 in Circulation Journal
Verified
Journal Article
Open access
RNRyuta Nakashima
Ryuta Nakashima
THToru Hifumi
Toru Hifumi
KKKenya Kawakita
Kenya Kawakita
TOTomoya Okazaki
Tomoya Okazaki
SESatoshi Egawa
Satoshi Egawa
YKYasuhiro Kuroda
Yasuhiro Kuroda
The discussion of neurocritical care management in post-cardiac arrest syndrome (PCAS) has generally focused on target values used for targeted temperature management (TTM). There has been less attention paid to target values for systemic and cerebral parameters to minimize secondary brain damage in PCAS. And the neurologic indications for TTM to produce a favorable neurologic outcome remain to be determined. Critical care management of PCAS patients is fundamental and essential for both cardiologists and general intensivists to improve neurologic outcome, because definitive therapy of PCAS includes both special management of the cause of cardiac arrest, such as coronary intervention to ischemic heart disease, and intensive management of the results of cardiac arrest, such as ventilation strategies to avoid brain ischemia. We reviewed the literature and the latest research about the following issues and propose practical care recommendations. Issues are (1) prediction of TTM candidate on admission, (2) cerebral blood flow and metabolism and target value of them, (3) seizure management using continuous electroencephalography, (4) target value of hemodynamic stabilization and its method, (5) management and analysis of respiration, (6) sedation and its monitoring, (7) shivering control and its monitoring, and (8) glucose management. We hope to establish standards of neurocritical care to optimize brain function and produce a favorable neurologic outcome.

30 May 2025 in Crohn's & Colitis 360
Verified
Journal Article
Open access
TATakahiro Amano
Takahiro Amano
TYTakeo Yoshihara
Takeo Yoshihara
TNTsutomu Nishida
Tsutomu Nishida
YSYuko Sakakibara
Yuko Sakakibara
TYTakuya Yamada
Takuya Yamada
TTTetsuo Takehara
Tetsuo Takehara
Background: There are currently no standardized guidelines for optimizing 5-aminosalicylic acid (5-ASA) maintenance treatment, particularly in patients with ulcerative colitis (UC) who have achieved clinical remission (CR). Therefore, this study examined the perspectives of patients and physicians regarding 5-ASA dose reduction and medication adherence to optimize maintenance treatment. Methods: This cross-sectional study was conducted from February 2023 to May 2023 at 19 institutions and included patients with UC and physicians. The participants’ perspectives were assessed using an anonymous questionnaire. Results: This study included 369 patients with UC (female, 43.1%; age, > 60 years, 29.3%; CR, 88.9%). Preference to reduce the 5-ASA dose and low medication adherence were observed in 46.1% and 16.0% of patients, respectively. Low medication adherence (odds ratio [OR]: 3.43, 95% confidence interval [CI]: 1.67–7.03) was associated with the preference to reduce the 5-ASA dose. Multivariate analysis for factors associated with low medication adherence revealed age < 60 years (OR: 10.25, 95% CI: 3.58–29.38), no intractable disease subsidy (OR: 2.63, 95% CI: 1.09–6.35), dosing frequency ≥ 2 times/day (OR: 9.04, 95% CI: 3.67–22.25), and preference to reduce the 5-ASA dose (OR: 2.57, 95% CI: 1.16–5.70) as significant. Among 153 physicians, 62.7% had > 10 years of experience, and 51.0% regularly verified adherence, with experience being a significant factor (OR: 2.01, 95% CI: 1.10–3.68). Conclusions: Factors influencing medication adherence with 5-ASA included patients’ desire for dose reduction and physicians’ lack of experience. Improving communication with patients and enhancing education for physicians could help optimize treatment with 5-ASA.

1 January 2021 in Rinsho Shinkeigaku
Verified
Journal Article
Open access
PDF file
SMSatoru Miyao
Satoru Miyao
YKYuichi Kubota
Yuichi Kubota
NNNaoto Nagino
Naoto Nagino
SESatoshi Egawa
Satoshi Egawa
HNHidetoshi Nakamoto
Hidetoshi Nakamoto
TKTakakazu Kawamata
Takakazu Kawamata
てんかん診療における不整脈の出現は突然死へとつながる可能性を有する.今回,致死性不整脈から心停止に陥り蘇生した1例を経験し,外来,急変前後,蘇生後,回復期まで,経時的な心電図変化を捉えた.心電図の経時的変化では,QT延長やブルガダ型波形が確認された.心電図変化を誘発する可能性を持つNaチャネル遮断薬,向精神薬との薬理作用,及び薬物動態的相互作用の認識の重要性に注目し,てんかん診療における心電図の重要性を強調した.